Wearable
OEMs
Integrate metabolic intelligence into watches.
- Differentiate devices with advanced health capabilities
- Increase user engagement and device stickiness
- Unlock new services and revenue streams
PARTNER WITH NEUTIGERS
Choose the path.
Build the program.
Device, life-science, research and commercialization partnerships.
Start a conversation ↗Wearable
Pharmaceuticals
- Patient identification
- Clinical trials
- Digital companion
- Enrich trials with the right high-risk populations
- Improve trial efficiency and reduce costs
- Engage and monitor patients with digital companion tools
Medical
Devices
- CGM integration
- Risk stratification
- Integrate with CGM and other medical devices
- Risk stratification for better clinical decisions
- Enhance device value and clinical adoption
Healthcare
Platforms
Remote risk screening at scale.
- Population-wide remote risk screening
- Early identification and care pathway activation
- Improve outcomes and reduce total cost of care
Payers /
Employers
- Population screening
- Lifestyle intervention
- Identify at-risk individuals early in the population
- Drive targeted lifestyle interventions
- Reduce claims, lower costs and improve productivity
One Platform. Multiple Markets. Massive Impact. SweetDeep™ brings clinically validated metabolic intelligence to every part of the healthcare value chain.
Clinically Validated Built on peer-reviewed science and real-world evidence.
Privacy by Design HIPAA/GDPR compliant with data minimization by default.
AI Edge-AI Enabled
Real-time intelligence on-device for speed and efficiency.
Globally Scalable Built to scale across populations, devices, and geographies.
Project
Internal
Kick-Off
Internal
Kick-Off
Study’s Design
Exploratory-Field Study
- Test the Apps
- Validate the data flow
- Adjust if needed the study design and amend associated protocol and regulatory documents
Study Design
- Identify the right KOLs/PIs
- Establish the specific use cases/ objectives of the study
- Consolidate the prospective study protocol
- Obtain regulatory approval (IRB
Study’s Planning
Study Clinic PI’s Kick-off
- Present the study to the medical team
- Assign the tasks and responsibilities
- Validate the feasibility of the study (human resources, devices, logistics, etc..)
Study Planning
- Medical team training
- Schedule of participants’ enrollment
- Establish the study timeline
Study’s Execution
Data Collection and Processing
- Gather, process and control quality (raw data and labeling)
- Augment data using synthetic data and data labeling solutions
Study Oversight
- Feedback of the medical team
- Integration of the trial tasks to their daily activity
- Provide adjustment if necessary
Signal Validation
- Conduct additional analyses to establish the signal is accurate, reliable and reproduceable
Algorithm DevOps
Algorithm Development
- Optimize on-device deep neural network (DNN) algorithm leveraging proprietary edge technology
Disease/
Wellness
Predictive
Algorithms
Wellness
Predictive
Algorithms
Partner’s Deployment
- Partner with client to deploy solution across all required platforms and divisions
- Continuously support client to update and further optimize AI algorithms as needed or required
WHO WE PARTNER WITH USEFUL STARTING INPUTS TYPICAL ENGAGEMENT
Wearable &
Device OEMs
Add differentiated, low-power health intelligence directly to connected products.
Device roadmap, sensor stack, compute envelope and target market.
Integration
· licensing
· co-development
Pharma &
Biotech
Generate continuous real-world evidence, enrich trials and explore digital companion pathways.
Therapeutic area, study objective, endpoints and participant profile.
Sponsored validation
· co-development
Providers &
Payers
Explore scalable risk identification, routing and preventive-care workflows.
Population, workflow, clinical objective and economic hypothesis.
Feasibility
· validation
· deployment
Research & Clinical
Institutions
Co-develop and validate digital biomarkers for high-unmet-need conditions.
Cohort, protocol, data access and scientific question.
Research collaboration
· sponsored study
OEM partner Samsung (South Korea)
Academic partner Princeton University (US)
4 Clinical studies completed / ongoing
3 Continents
US / EU / MENA
US / EU / MENA
$1.35M Non-dilutive funding & revenue milestones
$0.30M R&D grant with leading public research institute
CLINICAL VALIDATION
Diabetes + women’s health
- 4 studies across 3 continents
- Prospective multimodal sensor data
- Algorithms finalized for field validation
SAMSUNG PARTNERSHIP
Proof-to-commercial path
- Galaxy Watch POC completed
- Android + Wear OS apps operational
- Commercial licensing discussions next
STRATEGIC FUNDING
External validation
- TII, Samsung and France 2030 funded work
- MFDeep awarded $300K via France 2030
- Genopole supports EU clinical pathway
YOUR NEXT STEP